Moreover, overexpression of WT1 have been investigated in human HCC, related to poor prognosis of post-surgery patients and contributed to tumor progression and resistance to chemotherapy [10, 11], to explore a novel therapeutic approach for HCC, we investigated the causes of WT1 upregulation in HCC tumor tissue. This evidence concerns the gene WT1 and neoplasm.